Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia

NCT01380587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-08-27

No results posted yet for this study

Summary

The purpose of the study is to determine the utility of XCL1 in the prognosis of acute lymphoblastic leukemia.

Conditions

Sponsors & Collaborators

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • Cesar H Gutierrez Aguirre, MD · Hospital Universitario Dr. Jose E. Gonzalez UANL

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01380587 on ClinicalTrials.gov